ACC.23: Cardiovascular Sector Makes Some Noise

The sector is abuzz with clinical data presented at the 2023 American College of Cardiology Scientific Sessions & Expo.

Amanda Pedersen

March 6, 2023

4 Slides
3D illustration of a cardiovascular stent on a scientific background

Already have an account?

Image credit: Mohammed Haneefa Nizamudeen / iStock via Getty Images
Editor's note: These slides have been updated with key findings presented at the 2023 American College of Cardiology Scientific Sessions & Expo (ACC.23) over the weekend.

As expected, the cardiovascular sector made some noise in New Orleans, LA over the weekend at the 2023 American College of Cardiology Scientific Sessions & Expo (ACC.23).

The following slides cover late-breaking data in transcatheter aortic valve replacement (TAVR), transcatheter tricuspid valve repair (TTVr), pulsed field ablation (PFA), and mechanical thrombectomy for the treatment of pulmonary embolism (PE). The slides also include other recent clinical trial and regulatory news from the TAVR, TTVr, PFA, and mechanical thrombectomy sectors.

About the Author

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like